DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020379
» See Plans and Pricing
The generic ingredient in CAVERJECT is alprostadil. There are seven drug master file entries for this compound. Additional details are available on the alprostadil profile page.
Summary for 020379
Tradename: | CAVERJECT |
Applicant: | Pharmacia And Upjohn |
Ingredient: | alprostadil |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020379
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.01MG/VIAL | ||||
Approval Date: | Jul 6, 1995 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.02MG/VIAL | ||||
Approval Date: | Jul 6, 1995 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.005MG/VIAL | ||||
Approval Date: | Jun 27, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 020379
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-003 | Jun 27, 1996 | Start Trial | Start Trial |
Pharmacia And Upjohn | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-002 | Jul 6, 1995 | Start Trial | Start Trial |
Pharmacia And Upjohn | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-001 | Jul 6, 1995 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription